Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janusz H S Kabarowski

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|July 19, 2002
Lysophosphatidylcholine as a ligand for immunoregulationJanusz H S Kabarowski, Yan Xu, Owen N Witte
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout miceBrian W Parks, Aldons J Lusis, Janusz H S Kabarowski
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2009
ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cellsBrian W Parks, Roshni Srivastava, Shaohua Yu, et al.
Journal of Lipid Research|April 19, 2005
Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient miceBrian W Parks, Ginger P Gambill, Aldons J Lusis, et al.
Cancer Cell|June 28, 2002
Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogeneLu Q Le, Janusz H S Kabarowski, Stephane Wong, et al.
Journal of Neuroimmunology|January 13, 2009
Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitisInga Osmers, Sherry S Smith, Brian W Parks, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|July 19, 2002
Lysophosphatidylcholine as a ligand for immunoregulationJanusz H S Kabarowski, Yan Xu, Owen N Witte
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout miceBrian W Parks, Aldons J Lusis, Janusz H S Kabarowski
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2009
ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cellsBrian W Parks, Roshni Srivastava, Shaohua Yu, et al.
Journal of Lipid Research|April 19, 2005
Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient miceBrian W Parks, Ginger P Gambill, Aldons J Lusis, et al.
Cancer Cell|June 28, 2002
Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogeneLu Q Le, Janusz H S Kabarowski, Stephane Wong, et al.
Journal of Neuroimmunology|January 13, 2009
Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitisInga Osmers, Sherry S Smith, Brian W Parks, et al.
Pageof 1